Nurix Therapeutics, Inc. (NRIX)
26.19
-0.68
(-2.55%)
USD |
NASDAQ |
Aug 28, 16:00
26.19
0.00 (0.00%)
After-Hours: 20:00
Nurix Therapeutics Cash from Operations (Quarterly) : -96.57M for May 31, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -96.57M |
| February 28, 2026 | -71.91M |
| November 30, 2025 | -67.83M |
| August 31, 2025 | -57.38M |
| May 31, 2025 | -63.16M |
| February 28, 2025 | -61.09M |
| November 30, 2024 | -48.75M |
| August 31, 2024 | -42.18M |
| May 31, 2024 | -39.70M |
| February 29, 2024 | -41.95M |
| November 30, 2023 | 26.69M |
| August 31, 2023 | -41.13M |
| May 31, 2023 | -18.47M |
| February 28, 2023 | -48.45M |
| November 30, 2022 | -37.96M |
| Date | Value |
|---|---|
| August 31, 2022 | -46.31M |
| May 31, 2022 | -32.91M |
| February 28, 2022 | -42.63M |
| November 30, 2021 | -30.91M |
| August 31, 2021 | -29.97M |
| May 31, 2021 | -31.54M |
| February 28, 2021 | 8.053M |
| November 30, 2020 | -20.48M |
| August 31, 2020 | -6.141M |
| May 31, 2020 | -14.43M |
| February 29, 2020 | 40.97M |
| November 30, 2019 | -12.75M |
| August 31, 2019 | 36.37M |
| May 31, 2019 | -13.34M |
| February 28, 2019 | -9.682M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Monte Rosa Therapeutics, Inc. | -44.11M |
| Gilead Sciences, Inc. | 3.573B |
| TG Therapeutics, Inc. | 39.26M |
| Cue Biopharma, Inc. | -29.00M |
| Keros Therapeutics, Inc. | -20.42M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 93.00M |
| Cash from Financing (Quarterly) | 0.066M |
| Free Cash Flow | -304.53M |
| Free Cash Flow Per Share (Quarterly) | -0.8868 |
| Free Cash Flow to Equity (Quarterly) | -98.00M |
| Free Cash Flow to Firm (Quarterly) | -98.51M |
| Free Cash Flow Yield | -11.62% |